Literature DB >> 18047583

Sex- or gender-specific medicine in hepatology.

Sumiko Nagoshi1.   

Abstract

Sex- or gender-specific medicine is an up-to-date medical science in recent medical care. Medical doctors must offer better medical care and should understand and elucidate the mechanisms underlying the sex or gender differences regarding the incidence or etiology, clinical features, and natural history or response to therapies. Sex or gender differences are frequently seen among liver diseases, such as viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis and hepatocellular carcinoma. The mechanisms of sex or gender differences, however, are still unclear. Clinicians and basic scientists are required to cooperatively contribute to the development of sex- or gender-specific medicine to establish an accurate diagnosis and prophylaxis.

Entities:  

Year:  2007        PMID: 18047583     DOI: 10.1111/j.1872-034X.2007.00301.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  5 in total

Review 1.  Gender specific medicine in liver diseases: a point of view.

Authors:  Marilena Durazzo; Paola Belci; Alessandro Collo; Vanessa Prandi; Erika Pistone; Maria Martorana; Roberto Gambino; Simona Bo
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

2.  SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV.

Authors:  Kazuhiro Hamaoka; Sumiko Nagoshi; Kayoko Sugawara; Kayoko Naiki; Yoshihito Uchida; Mie Inao; Nobuaki Nakayama; Kenji Fujiwara; Satoshi Mochida
Journal:  Hepatol Int       Date:  2012-10-06       Impact factor: 6.047

3.  Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat.

Authors:  Tine M Comhair; Sonia C Garcia Caraballo; Cornelis Hc Dejong; Wouter H Lamers; S Eleonore Köhler
Journal:  Nutr Metab (Lond)       Date:  2011-01-24       Impact factor: 4.169

4.  Lessons from hepatocyte-specific Cyp51 knockout mice: impaired cholesterol synthesis leads to oval cell-driven liver injury.

Authors:  Gregor Lorbek; Martina Perše; Jera Jeruc; Peter Juvan; Francisco M Gutierrez-Mariscal; Monika Lewinska; Rolf Gebhardt; Rok Keber; Simon Horvat; Ingemar Björkhem; Damjana Rozman
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

5.  Sex differences in the hepatic cholesterol sensing mechanisms in mice.

Authors:  Gregor Lorbek; Martina Perše; Simon Horvat; Ingemar Björkhem; Damjana Rozman
Journal:  Molecules       Date:  2013-09-10       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.